Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Drug Resistance

Free Subscription Articles published in J Clin Microbiol Retrieve available abstracts of 99 articles: HTML format

Single Articles

June 2026
1. MISRA A
   Reporting macrolide-resistant Mycoplasma pneumoniae: a diagnostic obligation?
   J Clin Microbiol. 2026 Jun 30:e0016426. doi: 10.1128/jcm.00164.
   PubMed     Abstract available
   
   
   
2. WEISS ZF, Basu SS
   Point-Counterpoint: The "obsoletogram"-are annual hospital antibiograms still relevant?
   J Clin Microbiol. 2026;64:e0047626.
   PubMed     Abstract available
   
   
   
3. CHOW S-K, Stevig C, Granato P, Dhiman N, et al
   Performance of the LIAISON PLEX gram-positive blood culture assay for identifying bacterial pathogens and resistance genes in blood cultures.
   J Clin Microbiol. 2026;64:e0023526.
   PubMed     Abstract available
   
   
   
4. DHIMAN N, Emery CL, Chow S-K, Ho D, et al
   Performance of the LIAISON PLEX gram-negative blood culture assay for identifying bacterial pathogens and resistance genes in blood cultures.
   J Clin Microbiol. 2026;64:e0001826.
   PubMed     Abstract available
   
   
   May 2026
5. MCARDLE AJ, Austin V
   Further detail required to assess additional evidence on agreement between VITEK 2 and broth microdilution piperacillin/tazobactam testing in cephalosporin resistant Enterobacterales.
   J Clin Microbiol. 2026 May 14:e0029326. doi: 10.1128/jcm.00293.
   PubMed    
   
   
   
6. RICHTER SS, MacVane SH
   Reply to McArdle and Austin, "Further detail required to assess additional evidence on agreement between VITEK 2 and broth microdilution piperacillin/tazobactam testing in cephalosporin resistant Enterobacterales".
   J Clin Microbiol. 2026 May 14:e0033826. doi: 10.1128/jcm.00338.
   PubMed    
   
   
   
7. SIOPI M, Leventaki S, Pachoulis I, Rentoumi A, et al
   Evaluation of Sensititre YeastOne for antifungal susceptibility testing of Candida (Candidozyma) auris: misclassification of FKS1 mutants and overestimation of caspofungin resistance in a global collection of isolates.
   J Clin Microbiol. 2026 May 14:e0013026. doi: 10.1128/jcm.00130.
   PubMed     Abstract available
   
   
   
8. TODD GC, Vaida V, O'Brien B, Chaturvedi S, et al
   The emergence of superficial dermatophytosis due to Trichophyton indotineae and Trichophyton mentagrophytes genotypes VII and II* in New York: a need for comprehensive testing approaches.
   J Clin Microbiol. 2026;64:e0015626.
   PubMed     Abstract available
   
   
   
9. BRUKNER I, Oughton M
   The sampling bottleneck in antimicrobial susceptibility testing: consequences and paths forward.
   J Clin Microbiol. 2026;64:e0178825.
   PubMed     Abstract available
   
   
   April 2026
10. GREEN AL, Harris AD, Heller A, Vaeth E, et al
    Prevalence of Stenotrophomonas maltophilia colonization among patients receiving mechanical ventilation in long-term care facilities in Maryland, United States.
    J Clin Microbiol. 2026;64:e0162925.
    PubMed     Abstract available
    
    
    March 2026
11. RUDRA P, Parmar H, Daivaa N, Tran C, et al
    A cartridge-based assay for improved detection of multidrug-resistant Mycobacterium tuberculosis directly from sputum.
    J Clin Microbiol. 2026 Mar 30:e0110025. doi: 10.1128/jcm.01100.
    PubMed     Abstract available
    
    
    
12. MURPHY SG, Ross T, Fitzgerald A, Gauthier NPG, et al
    Detecting healthcare-associated transmission and antifungal resistance in Candida auris via whole genome sequencing.
    J Clin Microbiol. 2026 Mar 25:e0134825. doi: 10.1128/jcm.01348.
    PubMed     Abstract available
    
    
    
13. SIMNER PJ
    The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance.
    J Clin Microbiol. 2026 Mar 18:e0045125. doi: 10.1128/jcm.00451.
    PubMed     Abstract available
    
    
    
14. PATEL K, Shea J, Lapierre P, Halse TA, et al
    Predicting isoniazid resistance in Mycobacterium tuberculosis complex in New York State using whole-genome sequencing.
    J Clin Microbiol. 2026 Mar 18:e0160925. doi: 10.1128/jcm.01609.
    PubMed     Abstract available
    
    
    
15. ZAYDMAN MA, Glaser L, Herman DS, Kressloff M, et al
    Leveraging patient data to detect systematic shifts in daptomycin susceptibility testing associated with reduced prescribing.
    J Clin Microbiol. 2026;64:e0151025.
    PubMed     Abstract available
    
    
    February 2026
16. YANG Z, Ma Z, Liu Z, Li P, et al
    Accuracy of nanopore-based targeted next-generation sequencing assay for detection of Mycobacterium tuberculosis and drug resistance from non-sputum specimens: a multicenter prospective study in China.
    J Clin Microbiol. 2026 Feb 24:e0143325. doi: 10.1128/jcm.01433.
    PubMed     Abstract available
    
    
    
17. HENIN N, Silvant A, Gardette M, Balcon C, et al
    Clinical performance of two commercial PCR assays for the detection of macrolide resistance in Mycoplasma pneumoniae.
    J Clin Microbiol. 2026 Feb 13:e0149125. doi: 10.1128/jcm.01491.
    PubMed     Abstract available
    
    
    
18. WIESMANN N, Enders D, Westendorf A, Koch R, et al
    Correction for Wiesmann et al., "Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study".
    J Clin Microbiol. 2026 Feb 13:e0188425. doi: 10.1128/jcm.01884.
    PubMed    
    
    
    January 2026
19. LIN Y-T, Lin H-H, Chen C-H, Tseng K-H, et al
    Interpretive agreement of susceptibility between broth microdilution and disk diffusion methods for cefiderocol, using criteria from the Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing, and the F
    J Clin Microbiol. 2026;64:e0125525.
    PubMed     Abstract available
    
    
    
20. HOFFMANN H, Golubov A, Corbett C, Allamuratova D, et al
    Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB.
    J Clin Microbiol. 2026 Jan 12:e0138825. doi: 10.1128/jcm.01388.
    PubMed     Abstract available
    
    
    December 2025
21. ZHANG Y, Huo C, Zhang T, Liu Q, et al
    A novel Pyrococcus furiosus argonaute-based method for rapid and sensitive detection of Mycoplasma pneumoniae and a macrolide-resistance-related mutation.
    J Clin Microbiol. 2025 Dec 18:e0108925. doi: 10.1128/jcm.01089.
    PubMed     Abstract available
    
    
    
22. LEE E, Jung WS, Lim CS, Jang WS, et al
    Development of a LAMP assay using hybridization-based TaqMan-style probes (HyTaq) for simultaneous detection of wild-type and macrolide-resistant Mycoplasma pneumoniae.
    J Clin Microbiol. 2025 Dec 17:e0129125. doi: 10.1128/jcm.01291.
    PubMed     Abstract available
    
    
    
23. FENG Z, Ge S, Miao P, Liu M, et al
    Diagnostic performance of the Sanity 2.0 assay to detect resistance to rifampicin, isoniazid, and fluoroquinolones in tuberculosis.
    J Clin Microbiol. 2025 Dec 10:e0129925. doi: 10.1128/jcm.01299.
    PubMed     Abstract available
    
    
    November 2025
24. WIESMANN N, Enders D, Westendorf A, Koch R, et al
    Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study.
    J Clin Microbiol. 2025 Nov 26:e0118625. doi: 10.1128/jcm.01186.
    PubMed     Abstract available
    
    
    
25. XU Z, Huang Z, Yuan L, Wu H, et al
    Genomic surveillance reveals global spread of macrolide-resistant Bordetella pertussis linked to vaccine changes.
    J Clin Microbiol. 2025 Nov 14:e0106425. doi: 10.1128/jcm.01064.
    PubMed     Abstract available
    
    
    
26. SERNA C, Pulido-Vadillo M, Matamoros BR, Favieres JF, et al
    Persistent multispecies dissemination of armA-carrying IncR plasmids among clinical and environmental bacterial populations in a Spanish veterinary hospital.
    J Clin Microbiol. 2025;63:e0067325.
    PubMed     Abstract available
    
    
    October 2025
27. MARXREITER S, Marino J, Callan K, Hargrave J, et al
    Rapid detection of gram-negative antimicrobial resistance determinants directly from positive blood culture broths using a multiplex PCR system.
    J Clin Microbiol. 2025 Oct 21:e0038425. doi: 10.1128/jcm.00384.
    PubMed     Abstract available
    
    
    
28. YUKAWA K, Harada S, Komori K, Hayama B, et al
    Corynebacterium striatum infections in oncologic patients: clinical spectrum, resistance profiles, and evidence of nosocomial transmission.
    J Clin Microbiol. 2025;63:e0082925.
    PubMed     Abstract available
    
    
    
29. ARMSTRONG DT, Baird ECE, Pretty L, D'Agostino K, et al
    Diagnostics and new treatment regimens for TB: can the Xpert MTB/XDR assay fill the gap for fluoroquinolone testing?
    J Clin Microbiol. 2025;63:e0064325.
    PubMed     Abstract available
    
    
    September 2025
30. BRANDAO AP, Ferreira FMdA, Simeao FCdS, Ferrazoli L, et al
    Off-label evaluation of the BD MAX MDR-TB assay for rapid diagnosis of rifampicin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in a high-volume reference laboratory.
    J Clin Microbiol. 2025 Sep 23:e0091225. doi: 10.1128/jcm.00912.
    PubMed     Abstract available
    
    
    
31. SCHUETZ AN, Ferrell A, Hindler JA, Humphries R, et al
    Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions.
    J Clin Microbiol. 2025;63:e0162323.
    PubMed     Abstract available
    
    
    
32. FISCHER-WELLENBORN M, Imkamp F, Pereira Pires V, Zbinden R, et al
    Antibiotic resistance profiles of seven genomospecies of Corynebacterium jeikeium analyzed by whole genome sequencing.
    J Clin Microbiol. 2025 Sep 3:e0041825. doi: 10.1128/jcm.00418.
    PubMed     Abstract available
    
    
    
33. SANCHEZ BC, Sayeed H, Niles DT, Dunn JJ, et al
    ?Clinical performance of a syndromic panel for direct identification of pathogens and antimicrobial resistance markers in pediatric osteoarticular and pleural space infections.
    J Clin Microbiol. 2025 Sep 2:e0062125. doi: 10.1128/jcm.00621.
    PubMed     Abstract available
    
    
    August 2025
34. RAJAGOPALAN S, Das L, Kohlerschmidt DJ, Rourke AK, et al
    Luciferase reporter mycobacteriophage (TM4::GeNL) enables rapid assessment of drug susceptibilities and inducible macrolide resistance in Mycobacterium abscessus complex.
    J Clin Microbiol. 2025 Aug 20:e0084125. doi: 10.1128/jcm.00841.
    PubMed     Abstract available
    
    
    
35. SIMNER PJ, Harris H, Jacobs E, Stambaugh H, et al
    Establishing Clinical and Laboratory Standards Institute M45 antimicrobial susceptibility testing methods and breakpoints for Pseudomonas other than Pseudomonas aeruginosa.
    J Clin Microbiol. 2025;63:e0036825.
    PubMed     Abstract available
    
    
    July 2025
36. KOENIG C, Nicolau DP, Asempa T
    Sulbactam-durlobactam in combination with aztreonam and carbapenems against carbapenem-resistant Acinetobacter baumannii: an assessment using the MIC-based broth disk elution.
    J Clin Microbiol. 2025 Jul 24:e0070925. doi: 10.1128/jcm.00709.
    PubMed    
    
    
    
37. HARADA S, Komori K, Yukawa K, Hayama B, et al
    Genomic epidemiology and antimicrobial resistance of Corynebacterium macclintockiae, the predominant species of human pathogens within the Corynebacterium jeikeium complex.
    J Clin Microbiol. 2025 Jul 24:e0050025. doi: 10.1128/jcm.00500.
    PubMed     Abstract available
    
    
    
38. KUTI JL, Lutgring JD, Simner PJ, Naccache SN, et al
    Point-Counterpoint: Cascade reporting-useful tool to support antimicrobial stewardship, or dangerously misleading.
    J Clin Microbiol. 2025;63:e0170824.
    PubMed     Abstract available
    
    
    
39. PRIOR K, Becker K, Brandt C, Cabal Rosel A, et al
    Accurate and reproducible whole-genome genotyping for bacterial genomic surveillance with Nanopore sequencing data.
    J Clin Microbiol. 2025;63:e0036925.
    PubMed     Abstract available
    
    
    
40. SIOPI M, Leventaki S, Pachoulis I, Spruijtenburg B, et al
    Evaluation of the MIC test strips for antifungal susceptibility testing of Candidozyma auris (Candida auris) using a representative international collection of isolates.
    J Clin Microbiol. 2025 Jul 3:e0039925. doi: 10.1128/jcm.00399.
    PubMed     Abstract available
    
    
    
41. CALDERA JR, Dayo A, Wiederhold N, Yang S, et al
    Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction in Aspergillus fumigatus.
    J Clin Microbiol. 2025 Jul 1:e0029125. doi: 10.1128/jcm.00291.
    PubMed     Abstract available
    
    
    June 2025
42. MARBANIANG YV, Leto D, Almohri H, Hasan MR, et al
    Treatment and diagnostic challenges associated with the novel and rapidly emerging antifungal-resistant dermatophyte, Trichophyton indotineae.
    J Clin Microbiol. 2025;63:e0140724.
    PubMed     Abstract available
    
    
    
43. HARRIS H, Stambaugh H, Jacobs E, Bhalodi A, et al
    Defining antimicrobial susceptibility testing methods and breakpoints among Achromobacter species.
    J Clin Microbiol. 2025;63:e0026425.
    PubMed     Abstract available
    
    
    
44. TU C, Su B, Xiong Y, Xia Z, et al
    Identification and quantification of gyrA variants in fluoroquinolone-resistant Mycobacterium tuberculosis in a MeltArray reaction.
    J Clin Microbiol. 2025 Jun 3:e0014625. doi: 10.1128/jcm.00146.
    PubMed     Abstract available
    
    
    May 2025
45. SMITH DJ, Melhem MSC, Dirven J, de Azevedo CMPeS, et al
    Establishment of epidemiological cutoff values for Fonsecaea pedrosoi, the primary etiologic agent of chromoblastomycosis, and eight antifungal medications.
    J Clin Microbiol. 2025;63:e0190324.
    PubMed     Abstract available
    
    
    
46. DEMARCO MG, Field AM, Donohue LE, Cox HL, et al
    Impact of media brand on cefiderocol disk diffusion results.
    J Clin Microbiol. 2025;63:e0164824.
    PubMed     Abstract available
    
    
    
47. SOBKOWIAK A, Schwierzeck V, van Almsick V, Scherff N, et al
    The dark matter of bacterial genomic surveillance-antimicrobial resistance plasmid transmissions in the hospital setting.
    J Clin Microbiol. 2025 May 12:e0012125. doi: 10.1128/jcm.00121.
    PubMed     Abstract available
    
    
    April 2025
48. HUMPHRIES RM, Simner PJ
    Major updates to FDA-recognized Clinical and Laboratory Standards Institute breakpoints are a win for the fight against antimicrobial resistance.
    J Clin Microbiol. 2025 Apr 14:e0010625. doi: 10.1128/jcm.00106.
    PubMed     Abstract available
    
    
    
49. JIN Q-Y, Torres RC, Yang C, He LH, et al
    Population structure of Helicobacter pylori and antibiotic resistance-associated variants in a high-risk area of gastric cancer.
    J Clin Microbiol. 2025 Apr 11:e0003325. doi: 10.1128/jcm.00033.
    PubMed     Abstract available
    
    
    
50. DIERCKX L, Rodriguez-Ruiz JP, Ekinci E, van Heirstraeten L, et al
    Pneumococcal genotype 23B1 as a driver of increased 23B serotype carriage, penicillin non-susceptibility, and invasive disease in Belgium: a retrospective analysis.
    J Clin Microbiol. 2025;63:e0169624.
    PubMed     Abstract available
    
    
    
51. CZECH MM, Cuellar-Rodriguez J, Kwon-Chung KJ, Stock F, et al
    Clinical significance and antifungal susceptibility profile of 103 clinical isolates of Scedosporium species complex and Lomentospora prolificans obtained from NIH patients.
    J Clin Microbiol. 2025;63:e0155024.
    PubMed     Abstract available
    
    
    March 2025
52. EIGNER U, Koffer J, Betz U, Koglin J, et al
    Evaluation of the cobas MTB and MTB-RIF/INH assay in clinical samples for the detection of Mycobacterium tuberculosis in respiratory specimens.
    J Clin Microbiol. 2025 Mar 25:e0195924. doi: 10.1128/jcm.01959.
    PubMed     Abstract available
    
    
    
53. YU S, Liu N, Xie Z, Zeng Y, et al
    Nanopore sequencing for precise detection of Mycobacterium tuberculosis and drug resistance: a retrospective multicenter study in China.
    J Clin Microbiol. 2025 Mar 19:e0181324. doi: 10.1128/jcm.01813.
    PubMed     Abstract available
    
    
    February 2025
54. PEIRANO G, Pitout JDD
    Rapidly spreading Enterobacterales with OXA-48-like carbapenemases.
    J Clin Microbiol. 2025;63:e0151524.
    PubMed     Abstract available
    
    
    January 2025
55. MCTAGGART LR, Cronin K, Ruscica S, Patel SN, et al
    Emergence of terbinafine-resistant Trichophyton indotineae in Ontario, Canada, 2014-2023.
    J Clin Microbiol. 2025;63:e0153524.
    PubMed     Abstract available
    
    
    December 2024
56. PENVEN M, Louazon M, Freret C, Sauron A, et al
    Comparative performances of the Qvella FAST system and conventional methods for rapid identification and antibiotic susceptibility testing on monomicrobial positive blood cultures.
    J Clin Microbiol. 2024 Dec 20:e0133224. doi: 10.1128/jcm.01332.
    PubMed     Abstract available
    
    
    
57. WINKLER ML, Rhomberg PR, Fedler KA, Huband MD, et al
    Use of voriconazole to predict susceptibility and resistance to isavuconazole for Aspergillus fumigatus using CLSI methods and interpretive criteria.
    J Clin Microbiol. 2024 Dec 20:e0120724. doi: 10.1128/jcm.01207.
    PubMed     Abstract available
    
    
    
58. REN X, Suo B, Li C, Ping G, et al
    Comparative analysis of the detection of antibiotic genotypic resistance with gastric mucosa, gastric fluid, and fecal samples in patients with Helicobacter pylori infection.
    J Clin Microbiol. 2024 Dec 16:e0103424. doi: 10.1128/jcm.01034.
    PubMed     Abstract available
    
    
    
59. KHODADADI RB, El Zein S, Rivera O'Connor CG, Stevens RW, et al
    Retrospective analysis of antimicrobial susceptibility profiles of non-diphtheriae Corynebacterium species from a tertiary hospital and reference laboratory, 2012-2023.
    J Clin Microbiol. 2024;62:e0119924.
    PubMed     Abstract available
    
    
    November 2024
60. SABOUR S, Harrington KRV, Martinson E, Bhatnagar AS, et al
    Characterization of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa carrying multiple carbapenemase genes-Antimicrobial Resistance Laboratory Network, 2018-2022.
    J Clin Microbiol. 2024 Nov 20:e0122024. doi: 10.1128/jcm.01220.
    PubMed     Abstract available
    
    
    
61. CHAN H-H, Wang Y-C, Jou R
    A simplified pyrazinamidase test for Mycobacterium tuberculosis pyrazinamide antimicrobial susceptibility testing.
    J Clin Microbiol. 2024 Nov 18:e0122724. doi: 10.1128/jcm.01227.
    PubMed     Abstract available
    
    
    
62. OSTERMANN G, Korber-Irrgang B, Kruger A, Singh P, et al
    Performance evaluation of the Specific Reveal system for rapid antibiotic susceptibility testing from positive blood cultures containing Gram-negative pathogens.
    J Clin Microbiol. 2024 Nov 15:e0069224. doi: 10.1128/jcm.00692.
    PubMed     Abstract available
    
    
    
63. VALERIO DE LIMA A, Lima KdO, Cappellano P, Cifuentes S, et al
    Evaluation of the KPC/IMP/NDM/VIM/OXA-48 Combo Test Kit and Carbapenem-Resistant K.N.I.V.O. Detection K-Set in detecting KPC variants.
    J Clin Microbiol. 2024 Nov 14:e0112324. doi: 10.1128/jcm.01123.
    PubMed    
    
    
    
64. YOUNG EL, Roach DJ, Martinsen MA, McGrath GEG, et al
    Clinical pilot of bacterial transcriptional profiling as a combined genotypic and phenotypic antimicrobial susceptibility test.
    J Clin Microbiol. 2024;62:e0099724.
    PubMed     Abstract available
    
    
    
65. NG S, Tan CY, Yah JY, Osman NAB, et al
    Evaluation of the QIAstat-Dx BCID GN and GPF kits for direct identification and antimicrobial resistance prediction from blood culture bottles.
    J Clin Microbiol. 2024 Nov 6:e0116924. doi: 10.1128/jcm.01169.
    PubMed     Abstract available
    
    
    October 2024
66. MCHUGH JW, Bayless DR, Ranganath N, Stevens RW, et al
    Candida guilliermondii fungemia: a 12-year retrospective review of antimicrobial susceptibility patterns at a reference laboratory and tertiary care center.
    J Clin Microbiol. 2024 Oct 23:e0105724. doi: 10.1128/jcm.01057.
    PubMed     Abstract available
    
    
    
67. GISKE CG, Bressan M, Fiechter F, Hinic V, et al
    GPT-4-based AI agents-the new expert system for detection of antimicrobial resistance mechanisms?
    J Clin Microbiol. 2024 Oct 17:e0068924. doi: 10.1128/jcm.00689.
    PubMed     Abstract available
    
    
    September 2024
68. MANUEL C, Maynard R, Simpkins S, Haro M, et al
    Evaluation of an expanded antibiotic resistance gene panel on prediction of antimicrobial susceptibility results for Gram-negative bacteria in blood cultures.
    J Clin Microbiol. 2024 Sep 19:e0102024. doi: 10.1128/jcm.01020.
    PubMed     Abstract available
    
    
    
69. LUUKINEN B, Aittoniemi J, Miikkulainen-Lahti T, Mentula S, et al
    Evaluation of the STANDARD M10 MDR-TB and MTB/NTM assays for the detection of Mycobacterium tuberculosis, rifampicin and isoniazid resistance, and nontuberculous mycobacteria in a low-incidence setting.
    J Clin Microbiol. 2024 Sep 19:e0040224. doi: 10.1128/jcm.00402.
    PubMed     Abstract available
    
    
    
70. CABIBBE AM, Moghaddasi K, Batignani V, Morgan GSK, et al
    Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies.
    J Clin Microbiol. 2024 Sep 6:e0081524. doi: 10.1128/jcm.00815.
    PubMed     Abstract available
    
    
    August 2024
71. CHRISTIANS FC, Akhund-Zade J, Jarman K, Venkatasubrahmanyam S, et al
    Analytical and clinical validation of direct detection of antimicrobial resistance markers by plasma microbial cell-free DNA sequencing.
    J Clin Microbiol. 2024 Aug 28:e0042524. doi: 10.1128/jcm.00425.
    PubMed     Abstract available
    
    
    
72. SMITH A, Wong-O'Brien B, Lieberman JA, Cookson BT, et al
    The Brief Case: A case of tinea corporis caused by drug-resistant Trichophyton indotineae identified by broad-range fungal DNA sequencing.
    J Clin Microbiol. 2024;62:e0023424.
    PubMed    
    
    
    
73. PARANOS P, Pournaras S, Meletiadis J
    A single-layer spot assay for easy, fast, and high-throughput quantitation of phages against multidrug-resistant Gram-negative pathogens.
    J Clin Microbiol. 2024;62:e0074324.
    PubMed     Abstract available
    
    
    
74. WANG H
    Practical updates in clinical antiviral resistance testing.
    J Clin Microbiol. 2024;62:e0072823.
    PubMed     Abstract available
    
    
    July 2024
75. OMAR SV, Louw G, Ismail F, Liu X, et al
    Performance evaluation of the Xpert MTB/XDR test for the detection of drug resistance to Mycobacterium tuberculosis among people diagnosed with tuberculosis in South Africa.
    J Clin Microbiol. 2024 Jul 26:e0022924. doi: 10.1128/jcm.00229.
    PubMed     Abstract available
    
    
    June 2024
76. MOORE HP, Palumbo PJ, Notarte KI, Fogel JM, et al
    Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase.
    J Clin Microbiol. 2024;62:e0013624.
    PubMed     Abstract available
    
    
    
77. PEREYRE S, Henin N, Dolzy A, Guiraud J, et al
    Evaluation of commercial, customized microdilution plates for Ureaplasma parvum, Ureaplasma urealyticum, and Mycoplasma hominis antimicrobial susceptibility testing and determination of antimicrobial resistance prevalence in France.
    J Clin Microbiol. 2024 Jun 4:e0022624. doi: 10.1128/jcm.00226.
    PubMed     Abstract available
    
    
    May 2024
78. SERRANO-LOBO J, Reigadas E, Munoz P, Escribano P, et al
    Azole resistance screening in Aspergillus fumigatus sensu stricto using the azole-containing agar method (EUCAST E.Def 10.2): conidial suspension filtration and inoculum adjustment before inoculum preparation may not be needed.
    J Clin Microbiol. 2024 May 31:e0036924. doi: 10.1128/jcm.00369.
    PubMed     Abstract available
    
    
    
79. MUNSON E, Moore J, Krueger T, Zapp A, et al
    Mycoplasmoides genitalium nucleic acid semi-quantitation and molecular macrolide resistance detection via automated assays: gender and specimen source considerations.
    J Clin Microbiol. 2024 May 24:e0048524. doi: 10.1128/jcm.00485.
    PubMed     Abstract available
    
    
    
80. FOUAD A, Simner PJ, Nicolau DP, Asempa TE, et al
    Comparison of BD Phoenix and disk diffusion to broth microdilution for determining cefepime susceptibility among carbapenem-resistant Enterobacterales.
    J Clin Microbiol. 2024 May 7:e0152023. doi: 10.1128/jcm.01520.
    PubMed     Abstract available
    
    
    April 2024
81. BROWN-ELLIOTT BA, Wallace RJ Jr, Wengenack NL, Workman SD, et al
    Erratum for Brown-Elliott et al., "Emergence of Inducible Macrolide Resistance in Mycobacterium chelonae Due to Broad-Host-Range Plasmid and Chromosomal Variants of the Novel 23S rRNA Methylase Gene, erm(55)".
    J Clin Microbiol. 2024 Apr 4:e0041524. doi: 10.1128/jcm.00415.
    PubMed    
    
    
    
82. MCELVANIA E, Mindel S, Lemstra J, Brands K, et al
    Automated detection of methicillin-resistant Staphylococcus aureus with the MRSA CHROM imaging application on BD Kiestra Total Lab Automation System.
    J Clin Microbiol. 2024 Apr 1:e0144523. doi: 10.1128/jcm.01445.
    PubMed     Abstract available
    
    
    March 2024
83. PEIRANO G, Castellanos LR, Matsumura Y, Chaffee R, et al
    Clinical validation of loop-mediated isothermal amplification for the detection of Escherichia coli sequence type complex 131.
    J Clin Microbiol. 2024;62:e0168723.
    PubMed     Abstract available
    
    
    January 2024
84. MISAS E, Seagle E, Jenkins EN, Rajeev M, et al
    Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates.
    J Clin Microbiol. 2024 Jan 24:e0114023. doi: 10.1128/jcm.01140.
    PubMed     Abstract available
    
    
    
85. SIOPI M, Efstathiou I, Arendrup MC, Meletiadis J, et al
    Development of an agar-based screening method for terbinafine, itraconazole, and amorolfine susceptibility testing of Trichophyton spp.
    J Clin Microbiol. 2024;62:e0130823.
    PubMed     Abstract available
    
    
    
86. FRATONI AJ, Roberts AL, Nicolau DP, Kuti JL, et al
    Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid.
    J Clin Microbiol. 2024;62:e0113323.
    PubMed     Abstract available
    
    
    
87. SCHUETZ AN, Theel ES, Cole NC, Rothstein TE, et al
    Testing for Helicobacter pylori in an era of antimicrobial resistance.
    J Clin Microbiol. 2024 Jan 9:e0073223. doi: 10.1128/jcm.00732.
    PubMed     Abstract available
    
    
    
88. PFALLER MA, Carvalhaes CG, Rhomberg PR, Desphande LM, et al
    Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021).
    J Clin Microbiol. 2024 Jan 9:e0114123. doi: 10.1128/jcm.01141.
    PubMed     Abstract available
    
    
    December 2023
89. LOCKHART SR, Smith DJ, Gold JAW
    Trichophyton indotineae and other terbinafine-resistant dermatophytes in North America.
    J Clin Microbiol. 2023;61:e0090323.
    PubMed     Abstract available
    
    
    
90. MCTAGGART LR, Eshaghi A, Hota S, Poutanen SM, et al
    First Canadian report of transmission of fluconazole-resistant Candida parapsilosis within two hospital networks confirmed by genomic analysis.
    J Clin Microbiol. 2023 Dec 19:e0116123. doi: 10.1128/jcm.01161.
    PubMed     Abstract available
    
    
    
91. PRYCE TM, Foti OR, Haygarth EJ, Whiley DM, et al
    Maximizing the Neisseria gonorrhoeae confirmatory rate and the genotypic detection of ciprofloxacin resistance for samples screened with cobas CT/NG.
    J Clin Microbiol. 2023 Dec 12:e0103923. doi: 10.1128/jcm.01039.
    PubMed     Abstract available
    
    
    
92. FREY E, Stapleton GS, Nichols MC, Gollarza LM, et al
    Antimicrobial resistance in multistate outbreaks of nontyphoidal Salmonella infections linked to animal contact-United States, 2015-2018.
    J Clin Microbiol. 2023 Dec 12:e0098123. doi: 10.1128/jcm.00981.
    PubMed     Abstract available
    
    
    November 2023
93. MOSTAFA HH
    Next-generation sequencing for cytomegalovirus genotypic antiviral resistance testing.
    J Clin Microbiol. 2023 Nov 22:e0130223. doi: 10.1128/jcm.01302.
    PubMed     Abstract available
    
    
    
94. MALLORY MA, Hymas WC, Simmon KE, Pyne MT, et al
    Development and validation of a next-generation sequencing assay with open-access analysis software for detecting resistance-associated mutations in CMV.
    J Clin Microbiol. 2023 Nov 21:e0082923. doi: 10.1128/jcm.00829.
    PubMed     Abstract available
    
    
    
95. BHATNAGAR AS, Machado M-J, Patterson L, Anderson K, et al
    Antimicrobial Resistance Laboratory Network's multisite evaluation of the ThermoFisher Sensititre GN7F broth microdilution panel for antimicrobial susceptibility testing.
    J Clin Microbiol. 2023 Nov 16:e0079923. doi: 10.1128/jcm.00799.
    PubMed     Abstract available
    
    
    October 2023
96. DERBYSHIRE KM, Salfinger M
    Plasmid-mediated drug resistance in mycobacteria: the tip of the iceberg?
    J Clin Microbiol. 2023;61:e0062823.
    PubMed     Abstract available
    
    
    
97. LIU B, Gao J, Liu XF, Rao G, et al
    Direct prediction of carbapenem resistance in Pseudomonas aeruginosa by whole genome sequencing and metagenomic sequencing.
    J Clin Microbiol. 2023 Oct 12:e0061723. doi: 10.1128/jcm.00617.
    PubMed     Abstract available
    
    
    September 2023
98. SY I, Buhler N, Becker SL, Jung P, et al
    Evaluation of the Qvella FAST System and the FAST-PBC cartridge for rapid species identification and antimicrobial resistance testing directly from positive blood cultures.
    J Clin Microbiol. 2023 Sep 28:e0056923. doi: 10.1128/jcm.00569.
    PubMed     Abstract available
    
    
    
99. STRECK NT, Espy MJ, Ferber MJ, Klee EW, et al
    Use of next-generation sequencing to detect mutations associated with antiviral drug resistance in cytomegalovirus.
    J Clin Microbiol. 2023 Sep 26:e0042923. doi: 10.1128/jcm.00429.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum